Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 68, Issue 5, 2003, Pages 351-358

  Fujita, D ^a   Yamashita, N ^a   Iita, S ^a   Amano, H ^b   Yamada, S ^b   Sakamoto, K ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2; CELL RECEPTOR; GLYCOPROTEIN; OSTEOPROTEGERIN; PROSTAGLANDIN E RECEPTOR; TNFRSF11B PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; MALE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

MURINAE;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLYCOPROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 0038409066     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(03)00027-9     Document Type: Article

References (32)

1. T.J. Chamber, M.A. Horton, Failure of cells of the mononuclear phagocytes series to resorb bone, Calcif. Tissue Int. 36 (1984) 556-558.
2. W.S. Sly, D. Hewett-Emmett, W.P. Whyte, Y.S.L. Lu, R.E. Tashian, Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification, Proc. Natl. Acad. Sci. USA 80 (1983) 2752-2756.
3. H. Yoshida, S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L.D. Shultz, S. Nishikawa, The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulation factor gene, Nature 345 (1990) 442-444.
4. P. Soriano, C. Montgomery, R. Geske, A. Bradley, Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice, Cell 63 (1991) 693-702.
5. R. Lindsay, J.M. Aitken, D.M. Hart, D. Purdie, The effect of ovarian sex steroids on bone mineral status in the oophorectomized rat and in the human, Postgrad. Med. J. 54 (1978) 50-58.
6. T. Suda, I. Nakamura, E. Jimi, N. Takahashi, Regulation of osteoclast function, J. Bone Miner. Res. 12 (1997) 869-879.
7. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, T. Suda, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc. Natl. Acad. Sci. USA 95 (1998) 3597-3602.
8. N. Takahashi, T. Akatsu, N. Udagawa, T. Sasaki, A. Yamaguchi, J.M. Moseley, J. Martin, T. Suda, Osteoblastic cells are involved in osteoclast formation, Endocrinology 123 (1988) 2600-2602.
9. I.A. Ly, R.I. Mishell, Separation of mouse spleen cells by passage through column of sephadex G-10, J. Immunol. Methods 5 (1974) 239-247.
10. S. Niida, M. Kaku, H. Amanno, H. Yoshida, H. Kataoka, S. Nishikawa, K. Tanne, N. Maeda, S. Nishikawa, H. Kodama, Vascular endotherial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption, J. Exp. Med. 190 (1999) 293-298.
11. Q.R. Chen, C. Miyaura, S. Higashi, M. Murakami, I. Kudo, S. Saito, T. Hiraide, Y. Shibasaki, T. Suda, Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1, J. Biol. Chem. 272 (1997) 5952-5958.
12. H. Tai, C. Miyaura, C.C. Pilbeam, T. Tamura, Y. Ohsugi, Y. Koishihara, N. Kubodera, H. Kawaguchi, L.G. Raisz, T. Suda, Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation, Endoclinology 138 (1997) 2372-2379.
13. Y. Onoe, C. Miyaura, T. Kaminakayashiki, Y. Nagai, K. Noguchi, Q.R. Chen, H. Seo, H. Ohta, S. Nozawa, I. Kudo, T. Suda, IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts, J. Immunol. 156 (1996) 758-764.
14. A. Watabe, Y. Sugimoto, A. Honda, A. Irie, T. Namba, M. Negishi, S. Ito, S. Narumiya, A. Ichikawa, Cloning and expression of cDNA for a mouse EPI subtype of prostaglandin E receptor, J. Biol. Chem. 268 (1993) 20175-20178.
15. M. Negishi, Y. Sugimoto, A. Irie, S. Narumiya, A. Ichikawa, Opposite coupling of prostaglandin E receptor EP3C with Gs and Go stimulation of Gs and inhibition of Go, J. Biol. Chem. 217 (1993) 9517-9521.
16. A. Irie, Y. Sugimoto, A. Ichikawa, M. Negishi, Mouse prostaglandin E receptor EP3 subtype mediates calcium signals via Gi in cDNA-transfected Chinese hamster ovary cells, Biochem. Biophys. Res. Commun. 204 (1994) 303-309.
17. H. Hasegawa, H. Katoh, Y. Yamaguchi, K. Namba, S. Futakawa, M. Negishi, Different membrane targeting of prostagalandin EP3 receptor on their carboxyl-terminal tail structures, FEBS Lett. 473 (2000) 76-80.
18. T. Sando, T. Usui, I. Tanaka, K. Mori, Y. Sasaki, Y. Fukuda, T. Namba, Y. Sugimoto, A. Ichikawa, S. Narumiya, Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype, Biochem. Biophys. Res. Commun. 200 (1994) 1329-1333.
19. N. Nishigaki, M. Negishi, A. Honda, Y. Sugimoto, T. Namba, S. Narumiya, A. Ichikawa, Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype, FEBS Lett. 364 (1995) 339-341.
20. T. Namba, Y. Sugimoto, M. Negishi, A. Irie, F. Ushikubi, A. Kakizuka, S. Ito, A. Ichikawa, S. Narumiya, Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity, Nature 365 (1993) 166-170.
21. H. Katoh, A. Watabe, Y. Sugimoto, A. Ichikawa, M. Negishi, Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells, Biochim. Biophys. Acta. 1244 (1995) 41-48.
22. A. Watabe, Y. Sugimoto, A. Honda, A. Irie, T. Namba, M. Negishi, S. Ito, S. Narumiya, A. Ichikawa, Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor, J. Biol. Chem. 268 (1993) 20175-20178.
23. T. Suzawa, C. Miyaura, M. Inada, T. Maruyama, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, T. Suda, The role of prostaglandin E receptor subtypes (EP1, EP2, EP3 and EP4) in bone resorption: an analysis using specific agonists for the respective EPs, Endocrinology 141 (2000) 1554-1559.
24. Y.A. Mostafa, R.A. Meyer, R. Latorraca, Asimple and rapid method for osteoclast identification using a histochemical method for acid phosphatase, Histochem. J. 14 (1982) 409-413.
25. I. Itonaga, A. Sabokbar, S.D. Neale, N.A. Athanasou, 1, 25-Dihydroxyvitamin D3 and prostaglandin E2 act directly on circulating human osteoclast precursors, Biochem. Biophys. Res. Commun. 264 (1999) 590-595.
26. M.R. Wani, K. Fuller, N.S. Kim, Y. Choi, T. Chambers, Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hematopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion, Endocrinology 140 (1999) 1927-1935.
27. M. Mano, T. Arakawa, H. Mano, M. Nakagawa, T. Kaneda, H. Kaneko, T. Yamada, K. Miyata, H. Kiyomura, M. Kumegawa, Y. Hakeda, Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor, Calcif. Tissue Int. 67 (2000) 85-92.
28. Y. Sakuma, K. Tanaka, M. Suda, Y. Komatsu, A. Yasoda, M. Miura, A. Ozasa, S. Narumiya, Y. Sugimoto, A. Ichikawa, F. Ushikubi, K. Nakao, Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype, Infect. Immun. 68 (2000) 6819-6825.
29. X. Li, Y. Okada, C.C. Pilbeam, J.A. Lorenzo, C.R. Kennedy, R.M. Breyer, L.G. Raisz, Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro, Endocrinology 141 (2000) 2054-2061.
30. Y. Sakuma, K. Tanaka, M. Suda, A. Yasoda, K. Natsui, I. Tanaka, F. Ushikubi, S. Narumiya, E. Segi, Y. Sugimoto, A. Ichikawa, K. Nakao, Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide, J. Bone Miner. Res. 15 (2000) 218-227.
31. K. Ono, T. Akatsu, T. Murakami, M. Nishikawa, M. Yamamoto, N. Kugai, K. Motoyoshi, N. Nagata, Important role of EP4 a subtype of prostaglandin (PG) E receptor in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2, J. Endocrinol. 158 (1998) 1-5.
32. 2+-ionophore induce osteoclast-like cell formation in the cocultures of mouse bone marrow cells and carvarial cells, Biochem. Biophys. Res. Commun. 374 (1997) 111-115.